Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingyi Chen

Showing results (201-210 of 216) with videos related to

Pageof 22
Sort By:
Cancer Discovery|June 14, 2019
Loss of EZH2 Reprograms BCAA Metabolism to Drive Leukemic TransformationZhimin Gu, Yuxuan Liu, Feng Cai, et al.
European Journal of Haematology|March 18, 2025
Genomic Landscape of Mixed Phenotype Acute Leukemia Associated With Immunophenotypic Lineage Predominance: Impact on Diagnosis and TreatmentRuifang Zheng, Jeffrey R Gagan, Giovanni A Botten, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 29, 2002
Synthetic LXR ligand inhibits the development of atherosclerosis in miceSean B Joseph, Elaine McKilligin, Liming Pei, et al.
Journal for Immunotherapy of Cancer|September 20, 2023
Lenvatinib plus anti-PD-1 antibodies as conversion therapy for patients with unresectable intermediate-advanced hepatocellular carcinoma: a single-arm, phase II trialWenwen Zhang, Shuang Tong, Bingyang Hu, et al.
The Journal of Experimental Medicine|November 5, 2014
Adiposity induces lethal cytokine storm after systemic administration of stimulatory immunotherapy regimens in aged miceAnnie Mirsoian, Myriam N Bouchlaka, Gail D Sckisel, et al.
The Journal of Experimental Medicine|October 2, 2013
Aging predisposes to acute inflammatory induced pathology after tumor immunotherapyMyriam N Bouchlaka, Gail D Sckisel, Mingyi Chen, et al.
The Journal of Clinical Investigation|December 12, 2018
Tumor-conditional anti-CTLA4 uncouples antitumor efficacy from immunotherapy-related toxicityChien-Chun Steven Pai, Donald M Simons, Xiaoqing Lu, et al.
Human Pathology|June 19, 2026
Evaluation of Prognostic Factors and Outcomes in Primary versus Secondary Myeloid SarcomaChristine W Kahlow, Sharon Germans, Maximiliano Ramia de Cap, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 13, 2022
Human herpesvirus 8-negative effusion-based large B-cell lymphoma: a distinct entity with unique clinicopathologic characteristicsSavanah D Gisriel, Ji Yuan, Ryan C Braunberger, et al.
Cancer Cell|December 18, 2020
DNA Sensing in Mismatch Repair-Deficient Tumor Cells Is Essential for Anti-tumor ImmunityChangzheng Lu, Junhong Guan, Steve Lu, et al.
Pageof 22

Showing results (201-210 of 216) with videos related to

Sort By:
Pageof 22
Cancer Discovery|June 14, 2019
Loss of EZH2 Reprograms BCAA Metabolism to Drive Leukemic TransformationZhimin Gu, Yuxuan Liu, Feng Cai, et al.
European Journal of Haematology|March 18, 2025
Genomic Landscape of Mixed Phenotype Acute Leukemia Associated With Immunophenotypic Lineage Predominance: Impact on Diagnosis and TreatmentRuifang Zheng, Jeffrey R Gagan, Giovanni A Botten, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 29, 2002
Synthetic LXR ligand inhibits the development of atherosclerosis in miceSean B Joseph, Elaine McKilligin, Liming Pei, et al.
Journal for Immunotherapy of Cancer|September 20, 2023
Lenvatinib plus anti-PD-1 antibodies as conversion therapy for patients with unresectable intermediate-advanced hepatocellular carcinoma: a single-arm, phase II trialWenwen Zhang, Shuang Tong, Bingyang Hu, et al.
The Journal of Experimental Medicine|November 5, 2014
Adiposity induces lethal cytokine storm after systemic administration of stimulatory immunotherapy regimens in aged miceAnnie Mirsoian, Myriam N Bouchlaka, Gail D Sckisel, et al.
The Journal of Experimental Medicine|October 2, 2013
Aging predisposes to acute inflammatory induced pathology after tumor immunotherapyMyriam N Bouchlaka, Gail D Sckisel, Mingyi Chen, et al.
The Journal of Clinical Investigation|December 12, 2018
Tumor-conditional anti-CTLA4 uncouples antitumor efficacy from immunotherapy-related toxicityChien-Chun Steven Pai, Donald M Simons, Xiaoqing Lu, et al.
Human Pathology|June 19, 2026
Evaluation of Prognostic Factors and Outcomes in Primary versus Secondary Myeloid SarcomaChristine W Kahlow, Sharon Germans, Maximiliano Ramia de Cap, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 13, 2022
Human herpesvirus 8-negative effusion-based large B-cell lymphoma: a distinct entity with unique clinicopathologic characteristicsSavanah D Gisriel, Ji Yuan, Ryan C Braunberger, et al.
Cancer Cell|December 18, 2020
DNA Sensing in Mismatch Repair-Deficient Tumor Cells Is Essential for Anti-tumor ImmunityChangzheng Lu, Junhong Guan, Steve Lu, et al.
Pageof 22